ZimVie Past Earnings Performance
Past criteria checks 0/6
ZimVie has been growing earnings at an average annual rate of 43.8%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 9.3% per year.
Key information
43.8%
Earnings growth rate
13.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -9.3% |
| Return on equity | -13.7% |
| Net Margin | -12.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
ZimVie: Shrinking Its Way To Profitability
Feb 12ZimVie Inc. (NASDAQ:ZIMV) Stock Catapults 93% Though Its Price And Business Still Lag The Industry
Dec 19
ZimVie Inc.'s (NASDAQ:ZIMV) Shares Bounce 27% But Its Business Still Trails The Industry
Apr 17ZimVie: Disappointing Guidance Prompts Caution
Aug 25ZimVie Q2 Non-GAAP EPS beats, revenue down Y/Y, guidance reduced
Aug 10ZimVie: Undervalued Spin-Off
Jul 05ZimVie: Spin-Off Of Dental And Spine Units Of Zimmer Biomet
Apr 23Revenue & Expenses BreakdownBeta
How ZimVie makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 457 | -56 | 249 | 26 |
| 30 Sep 23 | 882 | -89 | 508 | 55 |
| 30 Jun 23 | 894 | -83 | 520 | 58 |
| 31 Mar 23 | 904 | -68 | 518 | 60 |
| 31 Dec 22 | 463 | -47 | 253 | 31 |
| 30 Sep 22 | 946 | -94 | 539 | 65 |
| 30 Jun 22 | 971 | -125 | 545 | 65 |
| 31 Mar 22 | 1,003 | -121 | 559 | 66 |
| 31 Dec 21 | 472 | 16 | 208 | 27 |
| 30 Sep 21 | 1,028 | 2 | 547 | 57 |
| 31 Dec 20 | 912 | -179 | 534 | 49 |
| 31 Dec 19 | 1,056 | -28 | 605 | 56 |
| 31 Dec 18 | 1,099 | -460 | 600 | 52 |
Quality Earnings: ZIMV is currently unprofitable.
Growing Profit Margin: ZIMV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZIMV is unprofitable, but has reduced losses over the past 5 years at a rate of 43.8% per year.
Accelerating Growth: Unable to compare ZIMV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZIMV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: ZIMV has a negative Return on Equity (-13.69%), as it is currently unprofitable.